Related Experiment Video
Updated: May 13, 2026

09:17
Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
Published on: September 13, 2022
Diffusion tensor invasive phenotypes can predict progression-free survival in glioblastomas.
1Department of Radiology, University of Cambridge , Cambridge , UK.
British Journal of Neurosurgery
|March 1, 2013
Summary
Diffusion tensor imaging (DTI) identified three glioblastoma invasion patterns. A minimally invasive phenotype showed significantly longer progression-free survival, suggesting a better prognosis.
Area of Science:
- Neuro-oncology
- Medical imaging
- Radiology
Background:
- Glioblastoma multiforme (GBM) is a highly aggressive brain tumor with poor prognosis.
- Tumor invasion into surrounding brain tissue limits treatment efficacy.
- Previous studies indicate variable GBM invasion patterns, ranging from <1 cm to >3 cm from the tumor core.
Purpose of the Study:
- To utilize Diffusion Tensor Imaging (DTI) to characterize GBM invasive patterns.
- To correlate identified invasion patterns with progression-free survival (PFS).
Main Methods:
- Retrospective analysis of 25 GBM patients treated per EORTC/NCIC protocol.
- Post-operative imaging using 1.5 T MRI with standard anatomical and DTI sequences.
- Classification of patients into diffuse, localized, or minimally invasive patterns based on DTI-derived p and q maps.
Main Results:
- Median PFS differed significantly across invasion patterns: 278 days (diffuse), 605 days (localized), and 820 days (minimally invasive).
- A minimally invasive pattern was associated with a significantly longer PFS.
- Three-quarters of patients with a minimally invasive phenotype remained progression-free at 24 months (p=0.010).
Conclusions:
- Diffusion tensor imaging can differentiate three distinct invasive phenotypes in GBM.
- These phenotypes exhibit significantly different progression-free survival outcomes.
- A minimally invasive GBM phenotype, observed in approximately 20% of patients, predicts a delayed progression.

